Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Apr;48(4):1374-8.
doi: 10.1128/AAC.48.4.1374-1378.2004.

Molecular characterization of the gene encoding a new AmpC beta-lactamase in a clinical strain of acinetobacter genomic species 3

Affiliations

Molecular characterization of the gene encoding a new AmpC beta-lactamase in a clinical strain of acinetobacter genomic species 3

Alejandro Beceiro et al. Antimicrob Agents Chemother. 2004 Apr.

Abstract

A presumptive chromosomal cephalosporinase (pI, 9.0) from a clinical strain of Acinetobacter genomic species 3 (AG3) is reported. The nucleotide sequence of this beta-lactamase shows for the first time the gene encoding an AmpC enzyme in AG3. In addition, the biochemical properties of the novel AG3 AmpC beta-lactamase are reported

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Nucleotide sequence of the 1.3-kb fragment. The amino acid sequence deduced for AmpC G3 β-lactamase is shown on the linebelow the nucleotide triplets. The ATG and TAA shown in boldface type represent the initiation and termination codons, respectively. A putative Shine-Dalgarno (S.D.) ribosomal recognition site is indicated. The positions of the primers used to sequence the gene and to detect the ampC gene in several AG3 strains are indicated by arrows. The positions of the primers used for amplification and further cloning of the gene are indicated by discontinuous arrows. The putative sequence of the signal peptide is indicated by boldface type and lowercase letters. The β-lactamase active site SVSK, the conserved triad KTG, and the typical class C motif YXN are shown in boldface type (12).

References

    1. Afzal-Shah, M., N. Woodford, and D. M. Livermore. 2001. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob. Agents Chemother. 45:583-588. - PMC - PubMed
    1. Bergogne-Bérézin, E., and K. J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical and epidemiological features. Clin. Microbiol. Rev. 9:148-165. - PMC - PubMed
    1. Blechschmidt, B., P. Borneleit, and H. P. Kleber. 1992. Purification and characterization of an extracellular β-lactamase produced by Acinetobacter calcoaceticus. J. Gen. Microbiol. 138:1197-1202. - PubMed
    1. Bou, G., and J. Martinez-Beltran. 2000. Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii. Antimicrob. Agents Chemother. 44:428-432. - PMC - PubMed
    1. Bouvet, P. J. M., and P. A. D. Grimont. 1986. Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. Nov., Acinetobacter haemolyticus sp. Nov. and amended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii. Int. J. Syst. Bacteriol. 36:228-240.

Publication types